Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Meiji Seika describes potent, broad-spectrum carbapenems

April 22, 1997

Merck KGaA prepares cardioprotective agents

April 22, 1997

PGE1 derivatives for peripheral circulatory disorders from Ono

April 22, 1997

Orally active antiplatelet agents disclosed by Mitsui Toatsu

April 22, 1997

Antitumor/antibacterial agent isolated by Microbial Chemistry Research Foundation

April 21, 1997

Mercian discloses novel anthracycline antibiotics

April 21, 1997

Cholesterol biosynthesis inhibitors described by Nippon Soda

April 21, 1997

Teijin and Microbial Chemistry Research Foundation reveal acetyl-CoA carboxylase inhibitor

April 21, 1997

Stable prostacyclins disclosed by Asahi Glass

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...